Zevra Therapeutics Q4 EPS $(0.26) Versus $(0.08) Last Year, Sales $2.30M Miss $3.20M Estimate
Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly losses of $(0.26) per share. This is a 225 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales